Elsevier Inc.

SHERPA: Unknown

People

  1. Devlin
    Devlin
  2. Ponce
    Ponce
  3. Giralt
    Giralt
  4. Perales
    Perales
  5. Papadopoulos
    Papadopoulos
  6. Young
    Young
  7. Jakubowski
    Jakubowski
  8. Dahi
    Dahi
  9. Scaradavou
    Scaradavou
  10. Castro-Malaspina
    Castro-Malaspina

Groups

  1. Biostatistics Service (63)
  2. Bone Marrow Transplant (63)
  3. CTCR Scholars (63)
  4. Center for Hematologic Malignancies (63)
  5. Department of Medicine (63)
  6. Epidemiology and Biostatistics (63)
  7. Hematologic Malignancies, Division of (63)
  8. MSK Grad Students (63)
  9. Master of Science in Clinical and Translational Cancer Research (63)
  10. Survivorship Research (51)
Search Within
  1. "Doris Ponce"
  2. "Sean Devlin"
Formats
  1. Meeting Abstract (46)
  2. Journal Article (17)
Groups
  1. Biostatistics Service (63)
  2. Bone Marrow Transplant (63)
  3. CTCR Scholars (63)
  4. Center for Hematologic Malignancies (63)
  5. Department of Medicine (63)
  6. Epidemiology and Biostatistics (63)

More Groups

People
  1. Doris Ponce (63)
  2. Sean Devlin (63)
  3. Sergio Giralt (59)
  4. Miguel-Angel Perales (51)
  5. Juliet Barker (50)
  6. Esperanza Papadopoulos (37)

More People

Years
  1. 2024 (1)
  2. 2022 (3)
  3. 2021 (3)
  4. 2020 (4)
  5. 2019 (7)
  6. 2018 (4)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (56)
  2. Transplantation and Cellular Therapy (7)

Results (63)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Reduced-intensity compared to nonmyeloablative conditioning in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic stem cell transplantation
    Journal Article

    Nath, K.; Peterson, K.; Brown, S.; Devlin, S.; Rodriguez, N.; Barker, J.; Giralt, S.; Gyurkocza, B.; Jakubowski, A.; Papadopoulos, E.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Peri-transplant vitamin and micronutrient status in allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Rodich, L.; Adintori, P. A.; Flynn, J.; Devlin, S. M.; Ruiz, J. D.; Gossman, Z.; Shike, M.; Barker, J. N.; Jakubowski, A. A.; Kernan, N. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Post-transplant Cyclophosphamide (PTCy) is associated with superior gvhd-free, relapse-free survival (GRFS) in HLA-mismatched unrelated donor (MMUD) hematopoietic cell transplantation
    Meeting Abstract

    Jimenez, A. M. J; Perales, M. A.; Devlin, S. M.; Brown, S.; Lekakis, L. J.; Sauter, C. S.; Pereira, D.; Wang, T. P.; Ponce, D. M.; Beitinjaneh, A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Double unit cord blood transplantation compares favorably to T-cell depleted matched adult donor transplantation for the treatment of acute leukemia due to a robust protection against relapse
    Meeting Abstract

    Politikos, I.; Flynn, J.; Devlin, S. M.; Fingrut, W.; Maloy, M. A.; Naputo, K.; Chinapen, S.; Rodriguez, N. T.; Quach, S.; Dominguez, Y.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Oral proteasome inhibitor ixazomib for switch-maintenance prophylaxis of recurrent or late acute and chronic graft-versus-host disease after day 100 in allogeneic stem cell transplantation
    Journal Article

    Rodriguez, N.; Lee, J.; Flynn, L.; Murray, F.; Devlin, S. M.; Soto, C.; Cho, C.; Dahi, P.; Giralt, S.; Perales, M. A.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Fractionated infusion of hematopoietic progenitor cells does not improve neutrophil recovery or survival in allograft recipients
    Journal Article

    Tamari, R.; Brown, S.; Devlin, S. M.; Kosuri, S.; Maloy, M. A.; Ponce, D. M.; Sauter, C.; Shaffer, B.; Dahi, P.; Young, J. W.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Relapse after allogeneic stem cell transplantation of acute myelogenous leukemia and myelodysplastic syndrome and the importance of second cellular therapy
    Journal Article

    Zuanelli Brambilla, C.; Lobaugh, S. M.; Ruiz, J. D.; Dahi, P. B.; Goldberg, A. D.; Young, J. W.; Gyurkocza, B.; Shaffer, B. C.; Ponce, D. M.; Tamari, R.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • The impact of individual co-morbidities in myeloablative ex vivo CD34+ selected allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Shouval, R.; Fein, J. A.; Devlin, S. M.; Maloy, M. A.; Castillo Flores, N.; Lin, R. J.; Politikos, I.; Sanchez, M.; Scordo, M.; Shah, G. L.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Don't let the HCT-CI fool you: Similar outcomes with myeloablative CD34+ selected allo-HCT compared to unmodified RIC allo-HCT in patients with AML or MDS and high comorbidity scores
    Meeting Abstract

    Pennisi, M.; Cho, C.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Tomas, A. A.; Castillo, N.; Lin, R. J.; Politikos, I.; Sanchez-Escamilla, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Long-term survival in patients with AML or MDS relapsed after allogeneic hematopoietic cell transplantation: Importance of second cell therapy
    Meeting Abstract

    Zuanelli Brambilla, C.; Ruiz, J. D.; Lobaugh, S. M.; Dahi, P. B.; Young, J. W.; Gyurkocza, B.; Shaffer, B. C.; Ponce, D. M.; Tamari, R.; Sanchez Escamilla, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save